Sanara Medtech Inc
NASDAQ:SMTI

Watchlist Manager
Sanara Medtech Inc Logo
Sanara Medtech Inc
NASDAQ:SMTI
Watchlist
Price: 32.64 USD 0.68% Market Closed
Market Cap: 285.3m USD
Have any thoughts about
Sanara Medtech Inc?
Write Note

Sanara Medtech Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sanara Medtech Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Sanara Medtech Inc
NASDAQ:SMTI
Free Cash Flow
-$2m
CAGR 3-Years
25%
CAGR 5-Years
4%
CAGR 10-Years
0%
Haemonetics Corp
NYSE:HAE
Free Cash Flow
$31.1m
CAGR 3-Years
-17%
CAGR 5-Years
-9%
CAGR 10-Years
2%
ICU Medical Inc
NASDAQ:ICUI
Free Cash Flow
$159.6m
CAGR 3-Years
-3%
CAGR 5-Years
123%
CAGR 10-Years
12%
Align Technology Inc
NASDAQ:ALGN
Free Cash Flow
$404.7m
CAGR 3-Years
-24%
CAGR 5-Years
-8%
CAGR 10-Years
7%
Lantheus Holdings Inc
NASDAQ:LNTH
Free Cash Flow
$378.6m
CAGR 3-Years
135%
CAGR 5-Years
49%
CAGR 10-Years
54%
Merit Medical Systems Inc
NASDAQ:MMSI
Free Cash Flow
$171m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
31%
No Stocks Found

Sanara Medtech Inc
Glance View

Market Cap
285.4m USD
Industry
Health Care

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 63 full-time employees. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. The surgical wound care products are used in specialties including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, oncology, plastic/reconstructive, podiatric, urology and vascular. The chronic wound care products are used across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities, and wound care centers.

SMTI Intrinsic Value
52.14 USD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Sanara Medtech Inc's Free Cash Flow?
Free Cash Flow
-2m USD

Based on the financial report for Sep 30, 2024, Sanara Medtech Inc's Free Cash Flow amounts to -2m USD.

What is Sanara Medtech Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
0%

Over the last year, the Free Cash Flow growth was 40%. The average annual Free Cash Flow growth rates for Sanara Medtech Inc have been 25% over the past three years , 4% over the past five years .

Back to Top